Outpatient transfusions and occurrence of serious noninfectious transfusion‐related complications among US elderly, 2007‐2008: utility of large administrative databases in blood safety research

BACKGROUND: Transfusion‐related acute lung injury (TRALI) and hemolytic transfusion reactions account for significant transfusion‐related morbidity and mortality in the United States. Our study evaluated types and quantities of transfused components as well as occurrence of TRALI, ABO, and Rh incompatibilities among the US elderly in the institutional outpatient setting during 2007 to 2008.

[1]  L. Dean.  ABO Blood Group , 2015 .

[2]  M. Gelderman,et al.  Ultraviolet B light–exposed human platelets mediate acute lung injury in a two‐event mouse model of transfusion , 2011, Transfusion.

[3]  B. Gathof,et al.  Generation of neutrophil priming activity by cell‐containing blood components treated with pathogen reduction technology and stored in platelet additive solutions , 2011, Transfusion.

[4]  B. Hauck,et al.  Influence of late irradiation on the in vitro RBC storage variables of leucoreduced RBCs in SAGM additive solution , 2011, Vox sanguinis.

[5]  J. Schwartz,et al.  How do I approach ABO‐incompatible hematopoietic progenitor cell transplantation? (CME) , 2011, Transfusion.

[6]  N. Blumberg,et al.  An association between decreased cardiopulmonary complications (transfusion‐related acute lung injury and transfusion‐associated circulatory overload) and implementation of universal leukoreduction of blood transfusions , 2010, Transfusion.

[7]  N. Juffermans.  Transfusion-related acute lung injury: emerging importance of host factors and implications for management , 2010, Expert review of hematology.

[8]  J. Binnekade,et al.  Risk factors and outcome of transfusion-related acute lung injury in the critically ill: A nested case–control study* , 2010, Critical care medicine.

[9]  A. Powers,et al.  IMMUNOHEMATOLOGY: Identification and evaluation of false‐negative antibody screens , 2009, Transfusion.

[10]  J. Linden.  Errors in transfusion medicine. Scope of the problem. , 2009, Archives of pathology & laboratory medicine.

[11]  C. Silliman,et al.  The role of neutrophils in the pathogenesis of transfusion-related acute lung injury. , 2009, Transfusion medicine reviews.

[12]  A. Eder,et al.  Noninfectious complications of blood transfusion. , 2009, Archives of pathology & laboratory medicine.

[13]  B. Meddeb,et al.  Transfusion-related acute lung injury (TRALI) during remission induction course of acute myeloid leukemia: a possible role for all-transretinoic-acid (ATRA)? , 2009, Pathologie-biologie.

[14]  S. Anderson,et al.  Blood use in the ambulatory setting among elderly in the United States , 2009, Transfusion.

[15]  Tina Bianco-Miotto,et al.  DNA Methylation of the ABO Promoter Underlies Loss of ABO Allelic Expression in a Significant Proportion of Leukemic Patients , 2009, PloS one.

[16]  R. Zimmermann,et al.  Influence of prestorage leukoreduction and subsequent irradiation on in vitro red blood cell (RBC) storage variables of RBCs in additive solution saline‐adenine‐glucose‐mannitol , 2009, Transfusion.

[17]  E. Strobel.  Hemolytic Transfusion Reactions , 2008, Transfusion Medicine and Hemotherapy.

[18]  N. D. Kalmin,et al.  Clinical outcomes of ABO-incompatible RBC transfusions. , 2008, American journal of clinical pathology.

[19]  M. Malinchoc,et al.  Transfusion-related acute lung injury in the critically ill: prospective nested case-control study. , 2007, American journal of respiratory and critical care medicine.

[20]  D. Triulzi,et al.  Immune hemolysis following ABO-mismatched stem cell or solid organ transplantation , 2007, Current opinion in hematology.

[21]  P. Toy,et al.  TRALI--definition, mechanisms, incidence and clinical relevance. , 2007, Best practice & research. Clinical anaesthesiology.

[22]  U. Sachs,et al.  The pathogenesis of transfusion‐related acute lung injury (TRALI) , 2007, British journal of haematology.

[23]  D. Stainsby.  ABO incompatible transfusions--experience from the UK Serious Hazards of Transfusion (SHOT) scheme Transfusions ABO incompatible. , 2005, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[24]  Jürgen Neppert,et al.  Re: Toward an understanding of transfusion‐related acute lung injury: statement of a consensus panel , 2005, Transfusion.

[25]  D. Stainsby.  Errors in transfusion medicine. , 2005, Anesthesiology clinics of North America.

[26]  Edward Abraham,et al.  Transfusion-related acute lung injury: definition and review. , 2005, Critical care medicine.

[27]  C. Silliman,et al.  Transfusion-related acute lung injury. , 2005, Blood.

[28]  Robertson Davenport,et al.  Toward an understanding of transfusion‐related acute lung injury: statement of a consensus panel , 2004, Transfusion.

[29]  M. Yazer,et al.  The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC , 2004, Transfusion.

[30]  S. Kleinman,et al.  Risks associated with transfusion of cellular blood components in Canada. , 2003, Transfusion medicine reviews.

[31]  C. Silliman,et al.  Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. , 2003, Blood.

[32]  F F Costa,et al.  Elastic properties of irradiated RBCs measured by optical tweezers , 2002, Transfusion.

[33]  A. Dobrovic,et al.  Loss of red cell A, B, and H antigens is frequent in myeloid malignancies. , 2001, Blood.

[34]  D. Howard,et al.  Red blood cell antigen changes in malignancy: case report and review , 2001, Immunohematology.

[35]  A E Voytovich,et al.  Transfusion errors in New York State: an analysis of 10 years' experience , 2000, Transfusion.

[36]  K. Tadokoro,et al.  Gamma-Ray-Irradiated Red Blood Cells Stored in Mannitol-Adenine-Phosphate Medium: Rheological Evaluation and Susceptibility to Oxidative Stress , 2000, Vox Sanguinis.

[37]  D. Bowen,et al.  Transfusion‐associated graft vs. host disease in a patient with high‐grade B‐cell lymphoma. Should cellular products for patients with non‐Hodgkin's lymphoma be irradiated? , 2000, British journal of haematology.

[38]  K. Sazama,et al.  Reports of 355 transfusion‐associated deaths: 1976 through 1985 , 1990, Transfusion.

[39]  I. Sniecinski,et al.  IMMUNOHEMATOLOGIC CONSEQUENCES OF MAJOR ABOMISMATCHED BONE MARROW TRANSPLANTATION , 1988, Transplantation.

[40]  L. Kux.  OF HEALTH AND HUMAN SERVICES Food and Drug Administration , 2014 .

[41]  M. Mathru.  An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions , 2012 .

[42]  อุดม ติ่งต้อย.  Identification and Evaluation of False-negative Antibody Screens , 2010 .

[43]  J. Freedman,et al.  Proceedings of a consensus conference: towards an understanding of TRALI. , 2005, Transfusion medicine reviews.

[44]  Laura Dean,et al.  Blood Groups and Red Cell Antigens , 2005 .

[45]  M. McBean,et al.  Administrative data for public health surveillance and planning. , 2001, Annual review of public health.

[46]  Serious hazards of transfusion (SHOT)--annual report 1997-1998. , 1999, Communicable disease report. CDR weekly.

[47]  T. Greenwalt,et al.  American Association of Blood Banks , 1959 .